These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 23000196

  • 1. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
    Shi QJ, Xiao L, Zhao B, Zhang XY, Wang XR, Xu DM, Yu SY, Fang SH, Lu YB, Zhang WP, Sa XY, Wei EQ.
    Brain Res; 2012 Nov 12; 1484():57-67. PubMed ID: 23000196
    [Abstract] [Full Text] [Related]

  • 2. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ, Wang H, Liu ZX, Fang SH, Song XM, Lu YB, Zhang WP, Sa XY, Ying HZ, Wei EQ.
    Neuroscience; 2015 Apr 16; 291():53-69. PubMed ID: 25681271
    [Abstract] [Full Text] [Related]

  • 3. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
    Zhang XY, Wang XR, Xu DM, Yu SY, Shi QJ, Zhang LH, Chen L, Fang SH, Lu YB, Zhang WP, Wei EQ.
    J Pharmacol Exp Ther; 2013 Aug 16; 346(2):328-41. PubMed ID: 23750020
    [Abstract] [Full Text] [Related]

  • 4. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH.
    Pharmacology; 2005 Jan 16; 73(1):31-40. PubMed ID: 15452361
    [Abstract] [Full Text] [Related]

  • 5. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia.
    Fang SH, Zhou Y, Chu LS, Zhang WP, Wang ML, Yu GL, Peng F, Wei EQ.
    Neurosci Lett; 2007 Jan 22; 412(1):78-83. PubMed ID: 17196746
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
    Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, Chu LS, Chen Z.
    Neuroscience; 2006 Jul 07; 140(3):969-79. PubMed ID: 16650938
    [Abstract] [Full Text] [Related]

  • 7. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
    Ni NC, Yan D, Ballantyne LL, Barajas-Espinosa A, St Amand T, Pratt DA, Funk CD.
    J Pharmacol Exp Ther; 2011 Dec 07; 339(3):768-78. PubMed ID: 21903747
    [Abstract] [Full Text] [Related]

  • 8. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
    Zhao R, Shi WZ, Zhang YM, Fang SH, Wei EQ.
    J Pharm Pharmacol; 2011 Apr 07; 63(4):550-7. PubMed ID: 21401607
    [Abstract] [Full Text] [Related]

  • 9. Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats.
    Zhao CZ, Zhao B, Zhang XY, Huang XQ, Shi WZ, Liu HL, Fang SH, Lu YB, Zhang WP, Tang FD, Wei EQ.
    Neuroscience; 2011 Aug 25; 189():1-11. PubMed ID: 21664436
    [Abstract] [Full Text] [Related]

  • 10. [Effects of cysteinyl leukotrienes receptor antagonists on chronic brain injury after global cerebral ischemia/reperfusion].
    Wang H, Guo H, Lou Q, Shi Q.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan 25; 47(1):19-26. PubMed ID: 30146807
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
    Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH.
    Acta Pharmacol Sin; 2002 Oct 25; 23(10):871-7. PubMed ID: 12370090
    [Abstract] [Full Text] [Related]

  • 12. C19, a C-terminal peptide of chemokine-like factor 1, protects the brain against focal brain ischemia in rats.
    Kong LL, Hu JF, Zhang W, Yuan YH, Han N, Chen NH.
    Neurosci Lett; 2012 Feb 02; 508(1):13-6. PubMed ID: 22155049
    [Abstract] [Full Text] [Related]

  • 13. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
    Huang XJ, Zhang WP, Li CT, Shi WZ, Fang SH, Lu YB, Chen Z, Wei EQ.
    Glia; 2008 Jan 01; 56(1):27-37. PubMed ID: 17910051
    [Abstract] [Full Text] [Related]

  • 14. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats.
    Zhao B, Zhao CZ, Zhang XY, Huang XQ, Shi WZ, Fang SH, Lu YB, Zhang WP, Xia Q, Wei EQ.
    Neuroscience; 2012 Jan 27; 202():42-57. PubMed ID: 22155652
    [Abstract] [Full Text] [Related]

  • 15. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats.
    Zhou Y, Fang SH, Ye YL, Chu LS, Zhang WP, Wang ML, Wei EQ.
    Acta Pharmacol Sin; 2006 Sep 27; 27(9):1103-10. PubMed ID: 16923329
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F, Tinel H, Kast R, Geerts A, Becker EM, Kolkhof P, Hütter J, Ergüden J, Härter M.
    Br J Pharmacol; 2010 May 27; 160(2):399-409. PubMed ID: 20423349
    [Abstract] [Full Text] [Related]

  • 17. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice.
    Chu LS, Wei EQ, Yu GL, Fang SH, Zhou Y, Wang ML, Zhang WP.
    Acta Pharmacol Sin; 2006 Mar 27; 27(3):282-8. PubMed ID: 16490162
    [Abstract] [Full Text] [Related]

  • 18. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
    Wang ML, Huang XJ, Fang SH, Yuan YM, Zhang WP, Lu YB, Ding Q, Wei EQ.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):399-404. PubMed ID: 17010308
    [Abstract] [Full Text] [Related]

  • 19. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ.
    Neurosci Lett; 2005 Oct 14; 387(1):5-10. PubMed ID: 16054296
    [Abstract] [Full Text] [Related]

  • 20. Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
    Yang Y, Bai X, Dong H, Lu Y, Xiong L.
    Neurosci Lett; 2011 Oct 31; 504(3):321-4. PubMed ID: 21982807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.